Clinical Trial Update: Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intralymphatic immunotherapy (ILIT) for house dust mite, cat, and dog allergens in allergic rhinitis patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Intralymphatic immunotherapy (ILIT) (Intralymphatic immunotherapy)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Allergic Rhinitis | Phase 1 | Status: TERMINATED